StockData
Theriva Biologics, Inc. logo

Theriva Biologics, Inc. (TOVX) KPIs and segments

TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.14+0.00 (0.00%)

Close on Nov 17, 2026Market cap $6.42MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Theriva Biologics's business

Coming soon

This tab will track the numbers specific to Theriva Biologics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?